glp-1 and type 1 diabetes In patients with residual ß-cell function, treatment Is GLP-1 the Same as
Description
BoeyDLinSEnriquezRFLeeNJSlackKCouzensMPA.et al
Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression
Omzo explicitly states it is not a medical practice and does not employ healthcare providers
Data from a total of 7,215 study participants were used
